Pharmassent supports pharmaceutical companies through the entire process of obtaining reimbursement regulatory approval. We can help your company pre-launch global pricing drug/medical device and help understand the complex reimbursement mechanisms.
If you choose to enter the reimbursable market (out-patients) for large distribution of pharmaceuticals, we help you understand that the margins of wholesalers and pharmacists are regulated, prices are set, and special mechanisms may apply to your drugs. Conversely, pricing is not set for the hospital market (in-patients) and negotiated after agreement, but subject to public procurement rules.
Your company needs to pursue a clear development plan to grow revenue and provide outcomes, with better financial impact on the product and company value.
As a result, Pharmassent can help you develop solid reimbursement strategy, analyze the environment and identify whether your drug/device can fits with existing codes or new ones that need to be created (LPPR – social security list).
Therefore and to encourage physicians and large hospitals to finance your drug/medical device so as to decrease time to market or to quickly obtain sources of payments such as third-party reimbursement (Caisse d’assurance maladie) or hospital budgets, Pharmassent can help you with a strategic and economic development model combining payment rates and coverage policies.
